Overview

PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
To investigate headache score and accompanying symptoms during and after infusion of PACAP38 i migraine patients
Phase:
N/A
Details
Lead Sponsor:
Danish Headache Center
Treatments:
Pituitary Adenylate Cyclase-Activating Polypeptide